Abstract: Methods and kits useful for diagnosis of prostate cancer are disclosed, based on levels of Human Carcino Antigen in semen or other biological samples.
Type:
Application
Filed:
May 11, 2005
Publication date:
December 8, 2005
Applicant:
Egenix, Inc.
Inventors:
John Mauck, Paul Schnipelsky, James Devanney